Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis
Authors
Keywords
Hexokinase 2, Cancer metabolism, Glycolysis, Cancer therapeutics
Journal
PHARMACOLOGICAL RESEARCH
Volume 164, Issue -, Pages 105367
Publisher
Elsevier BV
Online
2020-12-09
DOI
10.1016/j.phrs.2020.105367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure based discovery of novel hexokinase 2 inhibitors
- (2020) Yang Liu et al. BIOORGANIC CHEMISTRY
- Mitochondrial Dysfunction in Aging and Cancer
- (2019) Loredana Moro Journal of Clinical Medicine
- Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2
- (2017) Wei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 3′-Hydroxy-4′-methoxy-β-methyl-β-nitrostyrene inhibits tumor growth through ROS generation and GSH depletion in lung cancer cells
- (2017) Chun-Hao Tsai et al. LIFE SCIENCES
- An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
- (2016) Lianfeng Wu et al. CELL
- Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors
- (2016) Hong Lin et al. ACS Medicinal Chemistry Letters
- MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
- (2015) Weijie Guo et al. HEPATOLOGY
- The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions
- (2014) Matthew Glick et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An update on therapeutic opportunities offered by cancer glycolytic metabolism
- (2014) Carlotta Granchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors
- (2014) Ramon Salazar et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- (2013) Barbara Salani et al. Scientific Reports
- Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death
- (2012) E. C. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes
- (2011) Laura A. A. Gilliam et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
- (2010) K. A. Janeway et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
- (2008) Federica Chiara et al. PLoS One
- Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
- (2008) Saroj P. Mathupala et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now